BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8977303)

  • 1. CD40 engagement induces monocyte procoagulant activity through an interleukin-10 resistant pathway.
    Pradier O; Willems F; Abramowicz D; Schandené L; de Boer M; Thielemans K; Capel P; Goldman M
    Eur J Immunol; 1996 Dec; 26(12):3048-54. PubMed ID: 8977303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40 engagement on endothelial cells promotes tissue factor-dependent procoagulant activity.
    Zhou L; Stordeur P; de Lavareille A; Thielemans K; Capel P; Goldman M; Pradier O
    Thromb Haemost; 1998 May; 79(5):1025-8. PubMed ID: 9609241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the CD40 pathway of monocyte activation by triazolopyrimidine.
    Zhou L; Ismaili J; Stordeur P; Thielemans K; Goldman M; Pradier O
    Clin Immunol; 1999 Dec; 93(3):232-8. PubMed ID: 10600333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide.
    Pradier O; Gérard C; Delvaux A; Lybin M; Abramowicz D; Capel P; Velu T; Goldman M
    Eur J Immunol; 1993 Oct; 23(10):2700-3. PubMed ID: 8405069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10.
    Buelens C; Verhasselt V; De Groote D; Thielemans K; Goldman M; Willems F
    Eur J Immunol; 1997 Aug; 27(8):1848-52. PubMed ID: 9295017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages.
    Kennedy MK; Picha KS; Fanslow WC; Grabstein KH; Alderson MR; Clifford KN; Chin WA; Mohler KM
    Eur J Immunol; 1996 Feb; 26(2):370-8. PubMed ID: 8617306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of prostaglandins E1 and E2 on lipopolysaccharide-induced adhesion molecule expression on human monocytes.
    Takahashi HK; Iwagaki H; Tamura R; Katsuno G; Xue D; Sugita S; Mori S; Yoshino T; Tanaka N; Nishibori M
    Eur J Pharmacol; 2005 Apr; 512(2-3):223-30. PubMed ID: 15840408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production.
    Liu Z; Colpaert S; D'Haens GR; Kasran A; de Boer M; Rutgeerts P; Geboes K; Ceuppens JL
    J Immunol; 1999 Oct; 163(7):4049-57. PubMed ID: 10491009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of IL-1 induced tissue factor (TF) synthesis and procoagulant activity (PCA) in purified human monocytes by IL-4, IL-10 and IL-13.
    Osnes LT; Westvik AB; Joø GB; Okkenhaug C; Kierulf P
    Cytokine; 1996 Nov; 8(11):822-7. PubMed ID: 9047078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the CD40-CD40 ligand interaction in CD4+ T cell contact-dependent activation of monocyte interleukin-1 synthesis.
    Wagner DH; Stout RD; Suttles J
    Eur J Immunol; 1994 Dec; 24(12):3148-54. PubMed ID: 7528671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40 engagement strongly induces CD25 expression on porcine dendritic cells and polarizes the T cell immune response toward Th1.
    Pilon C; Levast B; Meurens F; Le Vern Y; Kerboeuf D; Salmon H; Velge-Roussel F; Lebranchu Y; Baron C
    Mol Immunol; 2009 Jan; 46(3):437-47. PubMed ID: 19036453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40 ligand-activated human monocytes amplify glomerular inflammatory responses through soluble and cell-to-cell contact-dependent mechanisms.
    Kuroiwa T; Lee EG; Danning CL; Illei GG; McInnes IB; Boumpas DT
    J Immunol; 1999 Aug; 163(4):2168-75. PubMed ID: 10438958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin engagement induces monocyte procoagulant activity and tumor necrosis factor production via induction of tyrosine phosphorylation.
    Dackiw AP; Nathens AB; Marshall JC; Rotstein OD
    J Surg Res; 1996 Aug; 64(2):210-5. PubMed ID: 8812635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocyte IL-10 produced in response to lipopolysaccharide modulates thrombin generation by inhibiting tissue factor expression and release of active tissue factor-bound microparticles.
    Poitevin S; Cochery-Nouvellon E; Dupont A; Nguyen P
    Thromb Haemost; 2007 Apr; 97(4):598-607. PubMed ID: 17393023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nuclear factor-kappaB inhibitor BAY11-7082 inhibits interactions between human endothelial cells, T cells, and monocytes.
    Zhu B; Liu Z; Wang P; Wu C; Xu H
    Transplant Proc; 2008 Oct; 40(8):2724-8. PubMed ID: 18929846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of CD40-CD40 ligand interaction on diacylglycerol-protein kinase C signal transduction pathway and intracellular calcium in cultured human monocytes.
    Yan JC; Wu ZG; Kong XT; Zong RQ; Zhang LZ
    Acta Pharmacol Sin; 2003 Jul; 24(7):687-91. PubMed ID: 12852836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells.
    Brossart P; Zobywalski A; Grünebach F; Behnke L; Stuhler G; Reichardt VL; Kanz L; Brugger W
    Cancer Res; 2000 Aug; 60(16):4485-92. PubMed ID: 10969796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dual role for both CD40-ligand and TNF-alpha in controlling human B cell death.
    Lens SM; Tesselaar K; den Drijver BF; van Oers MH; van Lier RA
    J Immunol; 1996 Jan; 156(2):507-14. PubMed ID: 8543800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
    Hirohata S
    Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligation of CD40 induced tumor necrosis factor-alpha in rheumatoid arthritis: a novel mechanism of activation of synoviocytes.
    Harigai M; Hara M; Nakazawa S; Fukasawa C; Ohta S; Sugiura T; Inoue K; Kashiwazaki S
    J Rheumatol; 1999 May; 26(5):1035-43. PubMed ID: 10332965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.